newsfilter
← Latest News
GlobeNewswire·

NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing

Workforce reductions of ~60% and implementation of a robust cost reduction plan are expected to extend the Company's cash runway into Q2 CY2024The Company plans to maximize shareholder value by focusing R&D resources